Application 211536
- Type
- ANDA
- Sponsor
- CIPLA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 5MG;500MG | No | No |
| 002 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MG;500MG | No | No |
| 003 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MG;1GM | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211536-001 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | |
| A211536-002 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 10MG;500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | |
| A211536-003 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 10MG;1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211536-001 | AB |
| A211536-002 | AB |
| A211536-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211536-001 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A211536-002 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 10MG;500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A211536-003 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 10MG;1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A211536-001 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A211536-002 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 10MG;500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A211536-003 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 10MG;1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211536-001 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211536-002 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 10MG;500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211536-003 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 10MG;1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2026-04-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211536-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A211536-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A211536-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A211536-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211536-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211536-003 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211536-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211536-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211536-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dapagliflozin and Metformin Hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Golden State Medical Supply, Inc. | 54027b70-53e7-3710-e063-6394a90aa04c | 2026-06-11 | Boxed warning, Warnings, Adverse reactions | Dapagliflozin and Metformin Hydrochloride |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Novadoz Pharmaceuticals LLC | 4f890458-be94-4baf-b606-83a097e1e23e | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE |
| Dapagliflozin and Metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 513bdf9f-774c-4f7f-935a-54d3885e80a4 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | Dapagliflozin and Metformin hydrochloride |
| dapagliflozin and metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Ascend Laboratories, LLC | eadcc3ef-f5c2-4a56-a6aa-12909844144e | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | dapagliflozin and metformin hydrochloride |
| dapagliflozin and metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Prasco Laboratories | eaf135b6-e378-4f62-a1e7-db45e23668c7 | 2024-12-20 | Boxed warning, Warnings, Adverse reactions | dapagliflozin and metformin hydrochloride |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.